Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 15:15:21 GMT 2023
by
admin
on
Sat Dec 16 15:15:21 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE GENETICALLY MODIFIED |
| Source Materials Parent | |
| Part | bone-marrow-and-peripheral-blood |
| Fraction Material Type | CELLS |
| Fraction Name | hematopoietic stem and progenitor cells |
| Record UNII |
MEE8487RTP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
390513
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MEE8487RTP
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
10900
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
GH-155
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
MEE8487RTP
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
Zynteglo
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
2610349
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY | |||
|
C123881
Created by
admin on Sat Dec 16 15:15:21 GMT 2023 , Edited by admin on Sat Dec 16 15:15:21 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
EXPRESSED PROTEIN->VECTOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CD34+ Enrichment | CELL SEPARATION | ||||
| LENTIVIRAL TRANSFECTION | BETIBEGLOGENE DAROLENTIVEC | 7VEJ4HT24J | |||
| CD34+ Cell Labeling | IMMUNOLOGICAL |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| VECTOR EXPRESSED PROTEIN | UNSPECIFIED SUBSTANCE |
f4353dfd
(not in database)
|
||||
| INSERTED GENE EXPRESSION VECTOR | UNSPECIFIED SUBSTANCE |
53ad4970
(not in database)
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
